Beyond VEGF, SRPK1 inhibition alters the splicing of MCL1/BIN1/BCL2 to produce pro-apoptotic isoforms in cholangiocarcinoma (39) and causes stress-associated cell death in lymphoma (48). Here, SRPK1 is linked to lymphoma.